BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23670242)

  • 1. Agent Orange as a risk factor for high-grade prostate cancer.
    Ansbaugh N; Shannon J; Mori M; Farris PE; Garzotto M
    Cancer; 2013 Jul; 119(13):2399-404. PubMed ID: 23670242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.
    Chamie K; DeVere White RW; Lee D; Ok JH; Ellison LM
    Cancer; 2008 Nov; 113(9):2464-70. PubMed ID: 18666213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agent orange exposure and prostate cancer risk in the million veteran program.
    Pagadala MS; Lui AJ; Zhong AY; Lynch JA; Karunamuni R; Lee KM; Plym A; Rose BS; Carter HK; Kibel AS; DuVall SL; Gaziano JM; Panizzon MS; Hauger RL; Seibert TM
    Acta Oncol; 2024 May; 63():373-378. PubMed ID: 38779869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to Agent Orange is a significant predictor of prostate-specific antigen (PSA)-based recurrence and a rapid PSA doubling time after radical prostatectomy.
    Shah SR; Freedland SJ; Aronson WJ; Kane CJ; Presti JC; Amling CL; Terris MK
    BJU Int; 2009 May; 103(9):1168-72. PubMed ID: 19298411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer detection in veterans with a history of Agent Orange exposure.
    Zafar MB; Terris MK
    J Urol; 2001 Jul; 166(1):100-3. PubMed ID: 11435832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Agent Orange and prostate cancer: a pilot case-control study.
    Giri VN; Cassidy AE; Beebe-Dimmer J; Ellis L; Smith DC; Bock CH; Cooney KA
    Urology; 2004 Apr; 63(4):757-60; discussion 760-1. PubMed ID: 15072895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agent Orange exposure, Vietnam war veterans, and the risk of prostate cancer.
    Schecter A; Needham L; Pavuk M; Michalek J; Colacino J; Ryan J; PƤpke O; Birnbaum L
    Cancer; 2009 Jul; 115(14):3369-71. PubMed ID: 19415730
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of the finasteride-adjusted Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator in a Mexican referral population: a validation study.
    Liang Y; Ketchum NS; Louden C; Jimenez-Rios MA; Thompson IM; Camarena-Reynoso HR
    Urol Int; 2012; 89(1):9-16. PubMed ID: 22626812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in investigating the association between Agent Orange and cancer: site-specific cancer risk and accuracy of exposure assessment.
    Sinks TH
    Cancer; 2014 Dec; 120(23):3595-7. PubMed ID: 25103199
    [No Abstract]   [Full Text] [Related]  

  • 10. Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study.
    Landgren O; Shim YK; Michalek J; Costello R; Burton D; Ketchum N; Calvo KR; Caporaso N; Raveche E; Middleton D; Marti G; Vogt RF
    JAMA Oncol; 2015 Nov; 1(8):1061-8. PubMed ID: 26335650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agent Orange exposure and cancer incidence in Korean Vietnam veterans: a prospective cohort study.
    Yi SW; Ohrr H
    Cancer; 2014 Dec; 120(23):3699-706. PubMed ID: 25103108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial comment on: Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.
    Shah SR; Terris MK
    Cancer; 2008 Nov; 113(9):2382-4. PubMed ID: 18661514
    [No Abstract]   [Full Text] [Related]  

  • 13. Does positive family history of prostate cancer increase the risk of prostate cancer on initial prostate biopsy?
    Elshafei A; Moussa AS; Hatem A; Ethan V; Panumatrassamee K; Hernandez AV; Jones JS
    Urology; 2013 Apr; 81(4):826-30. PubMed ID: 23434102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of Agent Orange on nonmelanoma skin cancer regression rates.
    Nosrati N; Han J; Flores R; Sood R; Tholpady SS
    JAMA Surg; 2014 Nov; 149(11):1205-6. PubMed ID: 25188833
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate cancer control and survival in Vietnam veterans exposed to Agent Orange.
    Everly L; Merrick GS; Allen ZA; Butler WM; Wallner K; Lief JH; Galbreath RW; Adamovich E
    Brachytherapy; 2009; 8(1):57-62. PubMed ID: 18955017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher body mass index increases the risk for biopsy-mediated detection of prostate cancer in Chinese men.
    Hu MB; Bai PD; Wu YS; Zhang LM; Xu H; Na R; Jiang HW; Ding Q
    PLoS One; 2015; 10(4):e0124668. PubMed ID: 25861033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agent Orange and long-term outcomes after radical prostatectomy.
    Ovadia AE; Terris MK; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Freedland SJ; Abern MR
    Urol Oncol; 2015 Jul; 33(7):329.e1-6. PubMed ID: 25998746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between Agent Orange and prostate specific antigen: a comparison of a hotspot and a non-sprayed area in Vietnam.
    Sun X; Kido T; Okamoto R; Manh HD; Hoang NV; Nakano M; Koh E; Maruzeni S; Nishijo M; Nakagawa H; Suzuki H; Honma S; Nhu DD; Hung NN; Son le K
    Environ Health Prev Med; 2013 Sep; 18(5):356-60. PubMed ID: 23526145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could Magnetic Resonance Imaging Help to Identify the Presence of Prostate Cancer Before Initial Biopsy? The Development of Nomogram Predicting the Outcomes of Prostate Biopsy in the Chinese Population.
    Fang D; Zhao C; Ren D; Yu W; Wang R; Wang H; Li X; Yin W; Yu X; Yang K; Liu P; Shan G; Li S; He Q; Wang X; Xin Z; Zhou L
    Ann Surg Oncol; 2016 Dec; 23(13):4284-4292. PubMed ID: 27464612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological features of mycosis fungoides in patients exposed to Agent Orange during the Vietnam War.
    Jang MS; Jang JG; Han SH; Park JB; Kang DY; Kim ST; Suh KS
    J Dermatol; 2013 Aug; 40(8):606-12. PubMed ID: 23724870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.